Air Liquide Expands ECO ORIGIN™ Initiative to Reduce Healthcare Carbon Footprint

An update from Air Liquide ( (FR:AI) ) is now available.

Air Liquide Healthcare has recently signed contracts with 19 hospitals and clinics in six European countries and one in Brazil to provide certified low-carbon medical gases through its ECO ORIGIN™ offering. This initiative aligns with the company’s strategic plan to support healthcare facilities in reducing their carbon footprint, contributing to a 70% reduction in carbon emissions related to medical gas supply. The move reflects a growing commitment in the healthcare sector to decrease environmental impact and supports Air Liquide’s mission to combine growth with sustainable progress.

More about Air Liquide

Air Liquide is a global leader in gases, technologies, and services for industry and health. With a presence in 60 countries and 66,300 employees, the company serves over 4 million clients and patients. Air Liquide focuses on essential molecules like oxygen, nitrogen, and hydrogen, which are crucial to life and energy. The company is committed to climate and energy transition, leveraging its innovation and technological expertise. Air Liquide reported a revenue of over 27.5 billion euros in 2023 and is listed on the Euronext Paris stock exchange.

YTD Price Performance: 3.67%

Average Trading Volume: 212,406

Technical Sentiment Consensus Rating: Sell

Current Market Cap: €93.19B

See more data about AI stock on TipRanks’ Stock Analysis page.